Literature DB >> 21157353

Brain stem responses evoked by stimulation of the mature cochlear nucleus with an auditory brain stem implant.

Martin O'Driscoll1, Wael El-Deredy, Richard T Ramsden.   

Abstract

OBJECTIVES: The Nucleus auditory brain stem implant (ABI) has been used in the hearing rehabilitation of totally deaf individuals for whom a cochlear implant is not an option such as in the case of neurofibromatosis type 2 (NF2). Intraoperative electrically evoked auditory brain stem responses (EABRs) are recorded to assist in the placement of the electrode array over the dorsal and ventral cochlear nuclei in the lateral recess of the IVth ventricle of the brain stem. This study had four objectives: (1) to characterize EABRs evoked by stimulation with an ABI in adolescents and adults with NF2, (2) to evaluate how the EABR morphology relates to auditory sensations elicited from stimulation by an ABI, (3) to establish whether there is evidence of morphology changes in the EABR with site of stimulation by the ABI, and (4) to investigate how the threshold of the EABR relates to behavioral threshold and comfortably loud sensations measured at initial device activation.
DESIGN: Intraoperative EABRs were recorded from 34 subjects with ABIs: 19 male and 15 female, mean age 27 yrs (range 12 to 52 yrs). ABI stimulation was applied at seven different sites using either wide bipolar stimulation across the array or in subsections of the array from medial to lateral and inferior to superior. The EABRs were analyzed with respect to morphology, peak latency, and changes in these characteristics with the site of stimulation. In a subset of eight subjects, additional narrow bipolar sites were stimulated to compare the intraoperative EABR threshold levels with the behavioral threshold (T) and comfortably loud (C) levels of stimulation required at initial device activation.
RESULTS: EABRs were elicited from 91% of subjects. Morphology varied from one to four vertex-positive peaks with mean latencies of 0.76, 1.53, 2.51, and 3.64 msecs, respectively. The presence of an EABR from stimulation by electrodes across the whole array had a high predictive value for the presence of auditory electrodes at initial device activation. When examining subsections of the array, the absence of an EABR was a poor predictor for the absence of auditory electrodes. The morphology of the EABRs varied with site of stimulation in 16 cases, but there was no consistent pattern of change with stimulation site. There was a trend for more auditory electrodes to be present in stimulation sites that evoked EABRs with a higher number of peaks in the waveform. The EABR threshold was closer to the behavioral C level than the T level, but there was no overall correlation between the intraoperative EABR threshold level and the behavioral T and C levels.
CONCLUSIONS: The presence of an intraoperative EABR corresponded well to the presence of auditory electrodes. The absence of an EABR from stimulating subsections of the array was not; however, a good indicator for the absence of auditory electrodes and the EABR from such stimulation would not be of assistance in identifying the nonauditory sections of the array to exclude in behavioral fitting of the device. The morphology of the EABR did not relate to site of stimulation. More peaks in the EABR was associated with a greater number of electrodes with auditory sensations, suggesting that correct positioning of the ABI activated more auditory subsystems within the cochlear nucleus. The intraoperative EABR thresholds did not correlate with the behavioral T and C levels and could not be used to assist in device fitting.

Entities:  

Mesh:

Year:  2011        PMID: 21157353     DOI: 10.1097/AUD.0b013e3181fc9d72

Source DB:  PubMed          Journal:  Ear Hear        ISSN: 0196-0202            Impact factor:   3.570


  7 in total

1.  Initial Results of a Safety and Feasibility Study of Auditory Brainstem Implantation in Congenitally Deaf Children.

Authors:  Eric P Wilkinson; Laurie S Eisenberg; Mark D Krieger; Marc S Schwartz; Margaret Winter; Jamie L Glater; Amy S Martinez; Laurel M Fisher; Robert V Shannon
Journal:  Otol Neurotol       Date:  2017-02       Impact factor: 2.311

2.  Auditory and audio-visual processing in patients with cochlear, auditory brainstem, and auditory midbrain implants: An EEG study.

Authors:  Irina Schierholz; Mareike Finke; Andrej Kral; Andreas Büchner; Stefan Rach; Thomas Lenarz; Reinhard Dengler; Pascale Sandmann
Journal:  Hum Brain Mapp       Date:  2017-01-28       Impact factor: 5.038

3.  Auditory brainstem implant: electrophysiologic responses and subject perception.

Authors:  Barbara S Herrmann; M Christian Brown; Donald K Eddington; Kenneth E Hancock; Daniel J Lee
Journal:  Ear Hear       Date:  2015 May-Jun       Impact factor: 3.570

4.  The electrically evoked cortical auditory event-related potential in children with auditory brainstem implants.

Authors:  Shuman He; Holly F B Teagle; Matthew Ewend; Lillian Henderson; Craig A Buchman
Journal:  Ear Hear       Date:  2015 May-Jun       Impact factor: 3.570

5.  Effect of anesthesia on evoked auditory responses in pediatric auditory brainstem implant surgery.

Authors:  Kevin Wong; Ruwan Kiringoda; Vivek V Kanumuri; Samuel R Barber; Kevin Franck; Nita Sahani; M Christian Brown; Barbara S Herrmann; Daniel J Lee
Journal:  Laryngoscope       Date:  2019-05-16       Impact factor: 3.325

6.  Electrically Evoked Auditory Event-Related Responses in Patients with Auditory Brainstem Implants: Morphological Characteristics, Test-Retest Reliability, Effects of Stimulation Level, and Association with Auditory Detection.

Authors:  Shuman He; Tyler C McFayden; Holly F B Teagle; Matthew Ewend; Lillian Henderson; Craig A Buchman
Journal:  Ear Hear       Date:  2016 Nov/Dec       Impact factor: 3.570

7.  Regulatory and funding strategies to develop a safety study of an auditory brainstem implant in young children who are deaf.

Authors:  Laurel M Fisher; Laurie S Eisenberg; Mark Krieger; Eric P Wilkinson; Robert V Shannon
Journal:  Ther Innov Regul Sci       Date:  2015-09       Impact factor: 1.778

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.